Just a thought.

Maybe a sales rep was deposed or has to answer questions pursuant to a discovery request in litigation and they want to see whether the answer complies with the intructions in this memo.

Cheers,

Evie

They may think have the documents onsite brings bad luck.

It continues to amaze me that the press hasn't given any coverage which considers the relatively small number of individuals who have sought redress in relationship the large number of individuals who have taken Zyprexa.

I'm just curious how you can tell who is accessing your site. Is this by tracing IP addresses? Just curious and technologically uninformed.

That's a bit spooky, to be honest. When the BMS story came up (ie, the payment of $515mm), I 'mailed the MHRA and asked it if paying quacks to prescribe drugs off-label was something that BMS was doing in the UK (yeah, I know, as if they'd answer in the affirmative, but I always find it valuable to ask the obvious question, first).

I also mailed my view to one of the BMS people named on its press release:

http://itsquiteanexperience.blogspot.com/2007/09/bristol-myers-squibb-finalizes.html

Anyway, the MHRA mailed me back saying that it had no knowledge of this kind of thing, so I thanked it for its time, and commented that it must just be in the US that this was going on...

The two incidents may be completely unrelated, of course.

Matt

Regarding coverage of Zyprexa - in 2003 there were three front page stories (Balt Sun, NYT, WSJ) which covered the lethal side effects. It took this effort to get the FDA to require the first warning on the label (diabetes, hyperglycemia, and death), which had been put on the labels in Japan and the UK all the way back in Spring 2002. While there have been other scattered stories, the only other major stories were those of Alex Berenson in the NYT last December and January revealing Lilly's internal documents.

It is astonishing to me after all the death and destruction and law suits that the FDA has not taken this drug off the market, but then, hey, it's the FDA, otherwise known as the Gold Standard.

It was the Spring of 2003 that my daughter, in high school added a "special circumstance" in her special education legal document IEP[Individualized Education Plan]for her to be able to eat a protein bar anytime of the day in any classroom.[school rules allow no food in class].She was starting to think about the connection of how she felt w Zyprexa, and besides the blood sugar issues, massive weight gain, there was agitation she connected to using it. But she was a kid. Try that discussion with a psychiatrist. She was ahead of her time. I agree with Evelyn, those snoops are just looking for legal recourse.
And, for Steve--I have a meter as well, that allows me to see who reads my blog. I have it in place to watch AstraZeneca, Eli Lilly, Medical Examiners, and Health departments, Universities, etc read my blog. For just being a mom, I've also got more interest that ever regarding Abilify, and that was from AstraZeneca.[they don't make Abilify].

Maybe they were reading up for the Alaska trial.